|
시장보고서
상품코드
1733242
세계의 브레인 컴퓨터 인터페이스(BCI) 시장 규모 : 제품, 용도, 최종사용자, 지역별(2026-2032년)Global Brain Computer Interface (BCI) Market Size By Product (Invasive, Partially invasive), Application (Healthcare, Smart Home Control), End-User (Medical, Military), & Region for 2026-2032 |
||||||
브레인 컴퓨터 인터페이스(BCI) 기술은 가상현실(VR) 헤드셋에 브레인 컴퓨터 인터페이스(BCI)를 통합하여 완전한 몰입 경험을 제공하는 가상 게임 산업과 모바일 게임 산업에서 널리 사용되고 있습니다. Verified Market Research의 애널리스트에 따르면, 브레인 컴퓨터 인터페이스(BCI) 시장은 2024년 약 40억 2,000만 달러로 평가되었고, 2032년에는 108억 6,000만 달러의 매출을 기록할 것으로 예측됩니다.
인간과 기계 감지 부문의 기술 개발과 엔터테인먼트, 게임, 커뮤니케이션 분야에서 뇌-컴퓨터 인터페이스(BCI) 기술의 광범위한 적용이 세계 뇌-컴퓨터 인터페이스(BCI) 시장의 성장을 견인하며 2026년부터 2032년까지 2032년까지 연평균 복합 성장률(CAGR) 14.61%를 보일 것으로 예측됩니다.
브레인 컴퓨터 인터페이스(BCI) 시장 정의/개요
신경제어 인터페이스, 직접 뉴럴 인터페이스, 브레인 머신 인터페이스, 마인드 머신 인터페이스는 브레인 컴퓨터 인터페이스(BCI)의 또 다른 이름입니다. 외부 장치와 유선으로 확대된 뇌는 브레인 컴퓨터 인터페이스 또는 BCI를 통해 서로 통신할 수 있습니다. 뇌 컴퓨터 인터페이스(BCI) 기술의 일반적인 응용은 인간의 감각 운동 능력의 연구, 지원, 매핑, 확대 및 회복입니다.
뇌-컴퓨터 인터페이스(BCI)는 기본적으로 뇌의 자극을 받아 처리하는 장치입니다. 그 후, 뇌의 충동은 다시 명령으로 변환되어 필요한 기능을 수행하는 출력 장치에 연결됩니다. 뇌-컴퓨터 인터페이스(BCI)의 주요 목적은 신경근육 질환 환자가 생명 유지 기능을 회복할 수 있도록 돕는 것입니다.
뇌-컴퓨터 인터페이스(BCI) 기술은 인간과 컴퓨터의 상호작용을 강화하는 혁신적인 솔루션에 대한 수요 증가 등 다양한 분야와 용도에 의해 주도되고 있으며, BCI 기술은 키보드나 터치스크린과 같은 기존 입력 방식을 우회하여 뇌 신호를 통해 기기 및 용도를 조작할 수 있게 합니다. 키보드나 터치스크린과 같은 기존의 입력 방식을 우회하여 뇌 신호를 통해 기기나 용도를 조작할 수 있게 해줍니다. 이는 신체 장애인의 접근성을 향상시키고, 의사소통, 기술과의 상호작용, 일상 업무의 자립을 가능하게 하는 큰 잠재력을 가지고 있습니다.
BCI 기반 뉴로피드백 시스템은 인지 훈련, 뇌졸중 및 외상성 뇌손상 후 재활, 간질 및 파킨슨병과 같은 신경 질환 관리, 게임, 교육, 자동차, 엔터테인먼트 등 산업 전반에 걸쳐 다양한 분야에 적용될 수 있습니다. BCI 기술과 신경과학 연구의 발전으로 게임, 교육, 자동차, 엔터테인먼트 등 산업 전반에 걸쳐 적용 범위와 이용 사례가 확대되고 있습니다. 뇌 제어 인터페이스는 사용자 경험을 향상시키고 몰입감을 높이며 새로운 상호작용 패러다임을 가능하게 합니다.
가상현실(VR), 증강현실(AR), 사물인터넷(IoT)과 같은 신기술과 BCI의 융합은 BCI 기술에 대한 관심과 채택을 촉진하고 있으며, VR/AR 플랫폼과의 통합은 몰입형 경험을 가능하게 하고, BCI를 IoT 기기와 결합하여 스마트 가전제품, 웨어러블 기기, 지원 기술을 원활하게 제어할 수 있게 합니다. 웨어러블 기기, 지원 기술의 원활한 제어를 가능하게 합니다.
뇌 컴퓨터 인터페이스(BCI) 시장은 뇌 신호의 복잡성과 가변성, 효과적인 사용자 교육 및 적응의 필요성, 정보 전송 속도 및 통신 대역폭의 제한 등 여러 가지 문제에 직면해 있으며, 뇌파 기반 BCI는 신호 노이즈, 인공물, 뇌의 해부학적 및 생리적 개인차와 관련된 문제에 직면해 있습니다. 생리적 개인차와 관련된 문제에 직면하는 경우가 많으며, 이는 BCI 시스템의 정확도와 신뢰성에 영향을 미칩니다. 이러한 문제를 해결하기 위해서는 첨단 신호 처리 기술, 머신러닝 알고리즘, 견고한 하드웨어 설계가 필요합니다. 사용자 교육도 BCI 시장의 과제입니다. 사용자는 일반적으로 뇌 신호를 변조하고 장치와 용도를 효과적으로 제어할 수 있도록 교육을 받습니다. 그러나 일부 사용자, 특히 심각한 운동 및 인지 장애를 가진 사용자에게는 시간이 많이 걸리고, 힘들고, 좌절감을 주는 훈련이 될 수 있습니다. 또한, 사용자의 참여와 동기를 유지하는 것은 어려운 일이며, 사용자 경험을 개선하고 기술 습득을 촉진할 수 있는 혁신적인 접근 방식이 필요합니다.
BCI는 신경 정보와 사고에 직접 접근할 수 있기 때문에 사용자의 동의, 데이터 안전성, 기밀성이 높은 뇌 데이터의 악용 가능성에 대한 의문이 제기될 수 있습니다. 신경 데이터의 프라이버시와 기밀성을 보장하고, 강력한 데이터 암호화 및 액세스 제어 수단을 도입하고, BCI 연구 및 개발에 대한 윤리적 가이드라인을 확립하는 것은 사용자, 의료 전문가 및 규제 당국의 신뢰를 구축하고 우려를 해소하는 데 필수적입니다.
The brain-computer interface (BCI) technology is widely being used in virtual and mobile gaming industries by integrating the brain-computer interface (BCI) within virtual reality (VR) headsets to offer a complete immersive experience. According to the analyst from Verified Market Research, the Brain Computer Interface (BCI) Market was valued to be around USD 4.02 Billion in 2024, subjugating the revenue of USD 10.86 Billion in 2032.
The technological developments in the field of human-machine sensing and extensive application of brain-computer interface (BCI) technology in entertainment, gaming, and communication are expected to drive the growth of the global brain-computer interface (BCI) market, enabling the market to grow at a CAGR of 14.61% from 2026 to 2032.
Brain Computer Interface (BCI) Market: Definition/ Overview
Neural control interfaces, direct neural interfaces, brain-machine interfaces, and mind-machine interfaces are other names for the brain-computer interface (BCI). An external device and a wired, augmented brain can communicate with each other through the brain-computer interface or BCI. A common application of brain-computer interface (BCI) technology is the study, support, mapping, augmentation, or restoration of human sensory-motor capabilities.
The brain-computer interface, or BCI, is essentially a device that receives and processes brain impulses. It is then converted once more into commands, which are subsequently connected to output devices that perform the required functions. The main goal of brain-computer interfaces, or BCIs, is to help individuals with neuromuscular illnesses regain vital functions.
Brain-Computer Interface (BCI) technology is being driven by various sectors and applications, including the increasing demand for innovative solutions to enhance human-computer interaction. BCI technology allows individuals to control devices and applications using their brain signals, bypassing traditional input methods like keyboards or touchscreens. This has immense potential for improving accessibility for individuals with physical disabilities, allowing them to communicate, interact with technology, and perform everyday tasks more independently.
The growing interest and investment in healthcare and medical applications are driving the adoption of BCI technology, as it holds promise for revolutionizing neurological diagnosis, rehabilitation, and treatment. BCI-based neurofeedback systems can be used for cognitive training, rehabilitation after stroke or traumatic brain injury, and managing neurological conditions like epilepsy or Parkinson's disease. Advancements in BCI technology and neuroscience research are expanding the range of applications and use cases across industries, such as gaming, education, automotive, and entertainment. Brain-controlled interfaces can enhance user experiences, increase immersion, and enable novel interaction paradigms.
The convergence of BCI with emerging technologies such as virtual reality (VR), augmented reality (AR), and Internet of Things (IoT) is driving interest and adoption in BCI technology. Integration with VR/AR platforms enables immersive experiences, while combining BCI with IoT devices allows for seamless control of smart home appliances, wearable devices, and assistive technologies.
The Brain-Computer Interface (BCI) market faces several challenges, including the complexity and variability of brain signals, the need for effective user training and adaptation, and limitations in information transfer rate and communication bandwidth. EEG-based BCIs often face issues related to signal noise, artifacts, and individual differences in brain anatomy and physiology, which affect the accuracy and reliability of BCI systems. To address these challenges, advanced signal processing techniques, machine learning algorithms, and robust hardware designs are needed. User training is another challenge in the BCI market. Users typically undergo training to modulate their brain signals and control devices or applications effectively. However, this can be time-consuming, labor-intensive, and frustrating for some users, particularly those with severe motor or cognitive impairments. Additionally, maintaining user engagement and motivation can be challenging, requiring innovative approaches to enhance user experience and facilitate skill acquisition.
Ethical and privacy concerns also pose significant challenges for market adoption and acceptance. As BCIs enable direct access to neural information and thoughts, questions arise regarding user consent, data security, and potential misuse of sensitive brain data. Ensuring the privacy and confidentiality of neural data, implementing robust data encryption and access control measures, and establishing ethical guidelines for BCI research and development are essential for building trust and addressing concerns among users, healthcare professionals, and regulatory authorities.
According to VMR analysis, partially invasive Brain-Computer Interfaces (BCIs) are a promising alternative to fully invasive approaches in the BCI market. They involve implanting electrodes or sensors beneath the skull, closer to the brain's surface, allowing for higher spatial resolution and signal fidelity. This proximity makes BCIs ideal for applications requiring fine-grained control, such as neuroprosthetics, robotic exoskeletons, and advanced assistive devices. They also offer long-term monitoring of neural activity, providing valuable insights into brain function and neurological disorders.
Partially invasive BCIs also contribute to technological innovation and research advancements in neuroscience, with the development of implantable neural interfaces, miniaturized electronics, and biocompatible materials driving advancements in areas like neural engineering, bioelectronics, and neuroprosthetics. These advancements not only improve the performance and usability of BCIs but also pave the way for future breakthroughs in brain-machine interfaces, neurorehabilitation, and cognitive enhancement.
Partially invasive BCIs offer user comfort, convenience, and acceptance compared to fully invasive approaches, making them more accessible to a broader range of users, including patients, researchers, and developers.
Brain-Computer Interface (BCI) technology is revolutionizing patient care, diagnosis, and treatment due to the increasing prevalence of neurological disorders and disabilities. BCI technology enables direct communication and control through brain signals, bypassing the need for intact motor function, providing a lifeline for individuals with neurological disabilities. The demand for personalized medicine and precision healthcare is driving interest in BCI technology as a tool for tailored interventions and treatments. BCI systems provide real-time feedback on brain activity and cognitive states, allowing healthcare providers to monitor patients' neurological status, assess treatment responses, and adjust therapies accordingly. Thus, enabling the medical industry dominate the market over the forecast period.
Advancements in neuro technology and neuroscience research are driving innovation and expanding the capabilities of BCI technology in the medical field. Remote healthcare delivery and telemedicine are driving the adoption of BCI technology for remote patient monitoring and telehealth consultations. Regulatory support and reimbursement policies are crucial in fostering the integration of BCI technology into mainstream medical practice. Reimbursement schemes and insurance coverage for BCI-enabled medical devices and services incentivize healthcare providers and patients to adopt BCI technology, driving market growth and facilitating broader access to innovative neurological interventions.
The Asia Pacific region is a key market for the Brain-Computer Interface (BCI) market due to its rapidly growing healthcare sector, increasing awareness of neurological disorders, and government initiatives to improve infrastructure. The region's diverse population, including China, Japan, South Korea, and India, presents a vast market for BCI technology adoption. The region's thriving technology and innovation ecosystem, including a startup culture, research institutions, and technology hubs, drives research and development efforts in BCI technology. The region's strong manufacturing capabilities and supply chain infrastructure support the production and distribution of BCI devices and components.
The increasing adoption of telemedicine and remote healthcare delivery in the Asia Pacific creates opportunities for BCI technology to address the growing demand for remote neurological assessments, monitoring, and therapy. This trend towards digital health and remote patient management is expected to drive demand for BCI technology as an integral component of telemedicine solutions in the Asia Pacific region.
The North American region is a leading player in the Brain-Computer Interface (BCI) market due to its robust ecosystem including research institutions, universities, technology companies, and venture capital firms. These institutions, including MIT, Stanford University, and the University of California, conduct pioneering research in BCI technology, fostering collaboration between academia and industry. The region also benefits from a favorable regulatory environment, with the U.S. Food and Drug Administration (FDA) providing clear pathways for the development and commercialization of medical devices, including BCI systems.
Major technology companies like Google, Facebook, and Neural ink are investing in BCI research and development, pushing the boundaries of BCI technology in healthcare, entertainment, and consumer electronics. The region's strong healthcare infrastructure, including world-class hospitals and medical centres, provides a fertile ground for clinical trials, validation studies, and adoption of BCI technology in healthcare settings. This collaborative ecosystem facilitates partnerships between technology developers and healthcare stakeholders to address unmet medical needs and deliver innovative neurological therapies and interventions to patients.
The competitive landscape in the Brain Computer Interface (BCI) Market's dynamic and evolving, driven by changing customer preferences, technological advancements, and market dynamics. Providers continue to innovate and differentiate their offerings to stay competitive and capture market share in this rapidly growing industry.
Some of the prominent players operating in the Brain Computer Interface (BCI) Market include:
Advanced Brain Monitoring, Inc.
Cadwell Industries, Inc.
Cortech Solutions, Inc.
Emotiv
Tec Medical Engineering Gmbh
Integra Lifesciences
Natus Medical Incorporated
Neurosky
Nihon Kohden Corporation
Openbci
Brain Computer Interface (BCI) Market Latest Developments:
In June 2022, with the assistance of remote-controlled robotic arms with the brain, an individual fed himself for the first time in the last 30 years. Researchers of John Hopkins University designed BCI to conduct a multi-step action that non-disabled individuals like us perform daily.
In June 2022, Pittsburgh's Rehab Neural Engineering Labs and Blackrock Neurotech are working closely on the first ever portable Brain-Computer Interface, allowing the patients to participate in the research trials from the comfort of their homes. Blackrock will successfully submit MoveAgain, its first commercial Brain Computer Interface device, to FDA this year, whereas it plans to launch it early next year.
In May 2022, the first patient in the US clinical trial, COMMAND, for patients having severe paralysis, was enrolled at the Mount Sinai Hospital in New York, according to Synchron, an endovascular brain-computer interface business. The FDA has granted the first investigational device exemption (IDE) to a company evaluating a permanently implanted BCI. Previous FDA-approved BCI human clinical trials took place in short-term test environments. The NIH-funded early feasibility study (EFS) will primarily test the safety and investigate quantitative efficacy measures of Synchron's StentrodeTM in patients with severe paralysis to allow the patients to control the digital devices without using their hands.
In March 2022, NexStem, a Robotics startup based in California, announced its BCI headset's launch in the US, APAC, and Europe. The headset can be readily controlled by the thoughts of the user. The launch comes after receiving funding from companies like InfoEdge based in India and BITS Spark. This NexStem headset which is absolutely Non-invasive, possesses 15 pins of dry EEG Electrodes and 16 channel EEG sensors that will first capture and then deliver EEG Signals which are absolutely accurate.
Brain Computer Interface (BCI) Market, by Category
Product:
Invasive
Partially invasive
Application:
Healthcare
Smart Home Control
End-User:
Medical
Military
Region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa